Global X Management Company’s Lexicon Pharmaceuticals LXRX Stock Holding History

Global X Management Company’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$54K	Buy	4,524 +2,452	+118%	+$25.1K	﹤0.01%	1071
2018 Q1	$18K	Buy	2,072 +521	+34%	+$4.82K	﹤0.01%	1118
2017 Q4	$15K	Buy	1,551 +352	+29%	+$3.66K	﹤0.01%	1037
2017 Q3	$15K	Buy	1,199 +173	+17%	+$2.56K	﹤0.01%	1085
2017 Q2	$17K	Buy	1,026 +686	+202%	+$10.6K	﹤0.01%	1178
2017 Q1	$5K	Buy	340 +20	+6%	+$297	﹤0.01%	1180
2016 Q4	$4K	Hold	320	–	–	﹤0.01%	1073
2016 Q3	$6K	Hold	320	–	–	﹤0.01%	1049
2016 Q2	$5K	Buy	+320	New	+$4.34K	﹤0.01%	931

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CLM

ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

SGA

Sector Gamma AS Oslo, Norway $461M AUM 33.26% 1-Year Est. Return

Global X Management Company's LXRX Position: Q2 2018 in Review

Global X Management Company increased its Lexicon Pharmaceuticals (LXRX) stake by 118% in Q2 2018, buying an estimated $25.1K and bringing the position to 4,524 shares worth $54K. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

Global X Management Company first reported a position in LXRX in Q2 2016 and has held it in 9 quarters since. 121 funds tracked by Wall St. Rank hold LXRX as of Q2 2018.

Global X Management Company held 4,524 shares of Lexicon Pharmaceuticals worth $54K as of Q2 2018.
Global X Management Company bought 2,452 Lexicon Pharmaceuticals shares in Q2 2018, an estimated $25.1K.
Lexicon Pharmaceuticals made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1071 holding.
Global X Management Company first reported a position in Lexicon Pharmaceuticals in Q2 2016 and has held it in 9 quarters since.
121 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.